Molecular Templates, Inc. (MTEM)

Molecular Templates Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	31.76	57.31	19.75	38.7	18.85	22.27
Revenue Growth (YoY)	-33.68%	190.10%	-48.95%	105.34%	-15.38%	67.63%
Gross Profit	31.76	57.31	19.75	38.7	18.85	22.27
Selling, General & Admin	16.83	18.9	26.2	34.11	26.72	20.08
Research & Development	37.24	48.88	82.43	84.67	92.97	50.52
Other Operating Expenses	0.48	0.48	0.07	0	2.16	22.12
Operating Expenses	54.54	68.25	108.69	118.77	121.84	92.72
Operating Income	-22.78	-10.94	-88.94	-80.07	-103	-70.45
Interest Expense / Income	1.29	2.65	4.72	3.37	1.71	1.3
Other Expense / Income	-5.66	-5.46	-0.99	-0.43	0.21	-2.33
Pretax Income	-18.41	-8.14	-92.67	-83.01	-104.91	-69.42
Income Tax	-0.01	-0.01	0.05	0	0.01	0
Net Income	-18.4	-8.12	-92.72	-83.01	-104.92	-69.42
Shares Outstanding (Basic)	5	5	4	4	3	3
Shares Outstanding (Diluted)	7	5	4	4	3	3
Shares Change	86.76%	19.85%	1.87%	16.16%	26.03%	27.60%
EPS (Basic)	-1.11	1.80	24.69	-22.50	-33.00	-27.90
EPS (Diluted)	-1.14	1.80	24.69	-22.50	-33.00	-27.90
EPS Growth	-	-92.71%	-	-	-	-
Free Cash Flow	-27.46	-41.76	-92.22	-34.38	-91.17	-34.89
Free Cash Flow Per Share	-5.11	-9.28	-24.56	-9.33	-28.73	-13.86
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-71.71%	-19.09%	-450.22%	-206.93%	-546.55%	-316.34%
Profit Margin	-57.92%	-14.18%	-469.36%	-214.51%	-556.73%	-311.72%
Free Cash Flow Margin	-86.45%	-72.87%	-466.85%	-88.85%	-483.81%	-156.68%
EBITDA	-11.28	1.16	-80.57	-73.01	-99.29	-66.94
EBITDA Margin	-35.51%	2.03%	-407.85%	-188.67%	-526.87%	-300.59%
Depreciation & Amortization	5.84	6.65	7.38	6.63	3.92	1.18
EBIT	-17.12	-5.48	-87.95	-79.64	-103.21	-68.12
EBIT Margin	-53.89%	-9.56%	-445.22%	-205.80%	-547.66%	-305.90%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).